Patents
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
06/2006
06/22/2006WO2006012385A3 Crystalline mycophenolate sodium
06/22/2006US20060135793 Process for the dimerisation of levulinic acid, dimers obtainable by such process and esters of such dimers
06/22/2006US20060135779 Process for the preparation n-(3,5-dichloropyrid-4-yl)-4-difluoromethoxy-8-methane sulfonamido-dibenzo[b,d]furan-1-carboxamide
06/22/2006US20060135770 PARP inhibitors
06/22/2006US20060135744 Fluorinated cyclic compound, polymerizable fluoromonomer, fluoropolymer, resist material comprising the same, and method of forming pattern with the same
06/22/2006US20060135597 Administering a bithiophene substituted by a carboxyalkyl group and a pyridinyl or pyrimidinyl group to treat irritable bowel syndrome, chronic heart failure, angina, cardiac infarction, cerebral infarction, pollakiuria, urinary incontinence, or, cerebral ischemia
06/22/2006US20060135568 Methods of treating microbial infections in humans and animals
06/22/2006US20060135532 Anticoagulants; antithrombotic agents in the treatment and prevention of thrombosis
06/22/2006US20060135502 Cyclic derivatives as modulators of chemokine receptor activity
06/22/2006US20060135487 Piperazine derivatives and their use as anti-inflammatory agents
06/22/2006US20060134724 Method and probe for identifying bacterial virulence modifying agents, agents thus identifed, and their use
06/22/2006CA2590330A1 Hydroxybiphenyl carboxylic acids and derivatives, method for producing the same and their use
06/22/2006CA2589495A1 2-arylpropionic acid derivatives and pharmaceutical compositions containing them
06/22/2006CA2588595A1 N-biaryl and n-arylheteroaryl piperazine derivatives as modulators of the 5ht2c receptor useful for the treatment of disorders related thereto
06/22/2006CA2588567A1 N-biaryl and n-arylheteroaryl 2-substituted piperazine derivatives as modulators of the 5ht2c receptor useful for the treatment of disorders related thereto
06/22/2006CA2588384A1 Tetrahydrocarbazoles as active agents for inhibiting vegf production by translational control
06/21/2006EP1670756A1 Heterocyclyl compounds
06/21/2006EP1670755A2 Pyrovalerone analogs and therapeutic uses thereof
06/21/2006EP1670749A1 2-substituted benzoic acid derivatives as hm74a receptor agonists
06/21/2006EP1341779B1 Heterocyclic sulfonamide inhibitors of beta amyloid production
06/21/2006EP1124818B1 Azadirachtin compounds extracted from azadirachta indica, compositions and use thereof as insecticidal
06/21/2006EP1049662B1 Inhibitors of alpha4 mediated cell adhesion
06/21/2006EP0957080B1 Novel ethylamine derivatives
06/21/2006CN1791572A Novel compounds
06/21/2006CN1791570A Aryl-carbaldehyde oxime derivatives and their use as estrogenic agents
06/21/2006CN1789257A Process for preparing tetrahydrofurfuryl alcohol by catalytic hydrogenation of furfuralcohol
06/21/2006CN1789256A Preparation of 2-methylfuran and cyclohexanone by couple method
06/21/2006CN1789255A Method for preparing gamma-butyrolactone and cyclohexanone by couple process
06/21/2006CN1789246A Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
06/21/2006CN1260229C Method for separating lycoramine from plant extract
06/21/2006CN1260228C Method for separating galanthamine from plant extract
06/21/2006CN1260222C Antagonists of mcp-1 function and methods of use thereof
06/21/2006CN1260218C PDF enzyme inhibitor-hydroxamic acid serial compounds, synthetic method and use thereof
06/21/2006CN1260214C Heterofluorene highly branched derivative with strong two photon absorption characteristics
06/21/2006CN1259912C Citalopram for the treatment of elevated blood pressure
06/20/2006US7064222 Processes for the preparation of 2-methylfuran and 2-methyltetrahydrofuran
06/20/2006US7064220 Production of furanones
06/20/2006CA2135480C Trisubstituted phenyl derivatives as phosphodiesterase inhibitors and processes for their preparation
06/20/2006CA2121523C Sulfonamide derivatives
06/15/2006WO2006063287A2 Conversion of 2,5-(hydroxymethyl) furaldehyde to 2,5-bis (hydroxymethyl) tetrahydofuran, purification and industrial uses of the product
06/15/2006WO2006063220A2 Preparation of 2,5-(hydr0xymethyl)furaldehyde (hmf) , derivatives thereof and levulinic acid from fructose as well as preparation of 2 , 5-bis- (hydroxymethyl) furan from 2 , 5- (hydroxymethyl) furaldehyde
06/15/2006WO2006062249A1 Substituted heterocyclic compound and thrombopoietin receptor activator
06/15/2006WO2006062137A1 High-purity oxydiphthalic acid anhydride and process for producing the same
06/15/2006WO2006062093A1 Novel anthranilic acid derivative or salt thereof
06/15/2006WO2006061392A2 Substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives
06/15/2006WO2006061215A2 2-alkyl-cycloalk(en)yl-carboxamides
06/15/2006WO2006037449A3 Iron complex for use in the treatment and/or prevention of nutritional disorders
06/15/2006WO2006010775A8 Tyrosine derivatives as ppar-gamma-modulators
06/15/2006WO2005085188A3 Compounds and methods for anti-tumor therapy
06/15/2006US20060128977 Conversion of 2,5-(hydroxymethyl)furaldehyde to industrial derivatives, purification of the derivatives, and industrial uses therefor
06/15/2006US20060128844 Conversion of 2,5-(hydroxymethyl)furaldehyde to industrial derivatives, purification of the derivatives, and industrial uses therefor
06/15/2006US20060128801 Organic compounds
06/15/2006US20060128747 To treat Gram-positive bacterial infections; antibacterial and/or antifungal properties; Preferably drug-resistant strains of bacteria
06/15/2006US20060128692 Non nucleoside reverse transcriptase inhibitors
06/15/2006US20060128670 Pesticidally active ketone and oxime derivatives
06/15/2006US20060128662 Novel compounds for treatment of obesity
06/15/2006US20060124017 New compounds, a process for their preparation and their use as dyes and pigments
06/15/2006CA2590220A1 2-alkyl-cycloalk(en)yl-carboxamides
06/15/2006CA2588760A1 Substituted tetracyclic tetrahydropyran, pyrrolidine and tetrahydrothiophene derivatives
06/15/2006CA2588633A1 Novel anthranilic acid derivative or salt thereof
06/15/2006CA2587928A1 Phenylpiperazines with a combination of affinity for dopamine -d2 receptors and serotonin reuptake sites
06/14/2006EP1669069A1 Compounds effecting glukokinase
06/14/2006EP1669068A1 Compounds effecting Glucokinase
06/14/2006EP1668008A2 Nitrosated ad nitrosylated diuretic compouds, compositions and methods of use
06/14/2006EP1667987A2 Process for the production of mycophenolate mofetil
06/14/2006EP1667959A1 Biphenyloxy-acids
06/14/2006EP1667955A2 Cycloalkylidene compounds as modulators of the estrogen receptor
06/14/2006EP1667676A1 4-(1-benzofuran-3-yl-methylideneaminoxy-propoxy)-benzoic acid derivatives and related compounds as pai-1 inhibitors for the treatment of impairement of the fibrinolytic system and of thrombisis
06/14/2006EP1667675A1 Entry inhibitors of the hiv virus
06/14/2006EP1667643A2 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
06/14/2006EP1309315B1 Rapidly disintegrating oral formulation of valdecoxib
06/14/2006EP1163553B1 Oxime derivatives and the use thereof as photoinitiators
06/14/2006CN1788240A Organic photoconductive material and electrophotographic photoreceptor and image forming device using same
06/14/2006CN1787994A 2,4,6-phenyl substituted cyclic ketoenols
06/14/2006CN1787989A Imino ether derivative compounds and drugs containing the compounds as the active ingredient
06/14/2006CN1785987A Large scale industrial production device and method of phthalic anhydride
06/14/2006CN1785986A Benzopyranone kind stabilizer and its application
06/14/2006CN1785985A Demethyl sodium cartharidate medicinal compound and its preparation method and application
06/14/2006CN1259307C Acylated indanyl amines and their use as pharmaceuticals
06/14/2006CN1259302C Method for extracting active component of diterpenes
06/13/2006US7060720 Compounds useful for treating or preventing IMPDH associated disorders, such as transplant rejection and autoimmune diseases and inhibitors of inosine-5'-monophosphate dehydrogenase). The compounds and pharmaceutical compositions
06/13/2006US7060718 Novel arylsulfonanilide derivatives and their use as pharmacologically active agents. The compositions find particular use as pharmacological agents in the treatment of disease states, particularly cancer, psoriasis, vascular
06/13/2006US7060649 for heterogeneously catalyzed gas-phase oxidation of butane to maleic anhydride; calcining vanadium, phosphorus and oxygen containing precursor particles having an averaged diameter of at least 2 mm moving at a steady speed; controlled variation over time of gas temperature in relation to set point value
06/13/2006US7060425 preventing the migration of oxidised developer by incorporating a substituted benzofuranone scavenger into an interlayer between light sensitive silver halide emulsion layers; photo, heat, oxygen resistance
06/13/2006CA2387997C Process for preparing oxazolines from tetrahydrofurans
06/13/2006CA2237194C Furan- and thiophenecarbothioamide derivatives, their preparation and their use as inhibitors of the replication of hiv-1 and hiv-1 mutants
06/13/2006CA2180008C Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents
06/08/2006WO2006059744A1 ACTIVATOR OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR δ
06/08/2006WO2006058700A1 Acetamide compounds as fungicides
06/08/2006WO2006058699A1 1-alkynyl-2-aryloxyalkylamides and their use as fungicides
06/08/2006WO2006028972A3 Mercaptoamides as histone deacetylase inhibitors
06/08/2006WO2006024610A3 Stabilization of organic materials
06/08/2006WO2006011024A9 New tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
06/08/2006WO2005120584A3 Radiolabeled arylsulfonyl compounds and uses thereof
06/08/2006WO2005107464A3 Compounds and compositions as cathepsin s inhibitors
06/08/2006WO2004085458A9 Steroid spirolactonization
06/08/2006US20060122390 Boronic ester and acid compounds, synthesis and uses
06/08/2006US20060122383 Antiviral methods employing double esters of 2', 3'-dideoxy-3'-fluoroguanosine
06/08/2006US20060122365 Method for producing tetrahydrofuran
06/08/2006US20060122265 Process for modifying drug crystal formation